Hillhouse Capital

Actionable Insights Powered by AI

WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business

WuXi AppTec; Hillhouse Capital; divestment; clinical research services; CRDMO; manufacturing; China; WuXi Clinical; MedKey